Clinical Trial Update: Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adding Lomustine to chemotherapy and allogeneic transplantation in older adults with acute myeloid leukemia; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lomustine (Lomustine)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED